SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (1196)6/23/1998 10:27:00 AM
From: Steve Harmon  Respond to of 2742
 
Normally this related news would help a small biotech like Cistron. A LOT!

Bluestone Capital>>>Where is the stock support?(They are giving us none because they want the remaining 400,000 warrants at or below these dirt cheap prices!)

Bruce Galton>>>You can't see this? Again you are ALLOWING this to happen.

Bruce>>>What you do is go ahead and give Bluestone Capital a price (say .25 or .30 cents a share) on the remaining 400,000 warrants IF they bring you a merger or partner.

That way Bluestone Capital SUPPORTS the stock instead of working against it.HINT! HINT!



To: scaram(o)uche who wrote (1196)6/23/1998 12:53:00 PM
From: Rudy Saucillo  Read Replies (1) | Respond to of 2742
 
biz.yahoo.com

Also in today's news, Oncor sells its research products division for $3.2MM to raise funds for commercialization of their HER-2/neu breast cancer diagnostic.

This would have been a nice, easily digestible business for CIST to acquire. In fact, Oncor wouldn't have been a bad fit before the sale.

Rudy